The state of Florida is examining whether Sun Pharmaceuticals (SUNPHARMA) has distributed samples of medicines without the proper permits, the third U.S. state to take such a step in the past year concerning one of the world’s largest purveyors of generic drugs.
Last month, the Division of Drugs, Devices, and Cosmetics became aware that Sun may have been distributing samples without filing necessary paperwork and so asked the company to explain its practices, according to a source familiar with the matter. Walter Copeland, the division director, declined to comment.
About the Author Reprints
